Hanhua Huang
Vice President Avidity Biosciences
Hanhua Huang is a scientist with >20 years of industrial experience in leading multi-disciplinary early drug discovery and development teams in immuno-oncology, pain and muscular diseases using various therapeutic moieties, such as peptides, oligonucleotides, and antibody conjugates. At Avidity, Hanhua led teams to develop antibody oligonucleotide conjugates (AOCs) for immune cells, cancer cells, and muscle cells for various indications.
Seminars
Monday 23rd February 2026
Spotlighting Emerging Clinical Profiles of AOCs for Precision Therapy Applications in Muscle & Cardiac Diseases
2:00 pm
- Understanding AOC novel therapeutic approaches for targeted oligonucleotide delivery to skeletal and cardiac tissues
- Showcasing early clinical promise of AOCs in treating rare muscle diseases like DM1, FSHD, and DMD
- Explaining AOC platform extension to precision cardiology, expanding the potential of oligonucleotide-based therapies
